Skip to Main Content

Author Details

Ryoji Matsumoto
Atopy Research Center, Juntendo University Graduate School of Medicine
1989
40
23
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33975012Analysis of therapeutic potential of monocytic myeloid-derived suppressor cells in cardiac allotransplantation.Transpl Immunol2021
28163596RAD-Seq analysis of typical and minor <i>Citrus</i> accessions, including Bhutanese varieties.Breed Sci2016
24781859Characterization of limes (Citrus aurantifolia) grown in Bhutan and Indonesia using high-throughput sequencing.Sci Rep2014
23638116Phylogenetic relationships of citrus and its relatives based on matK gene sequences.PLoS One2013
21737285Discovery of selective indole-based prostaglandin Dâ¿¿ receptor antagonist.Bioorg Med Chem2011
21885288Design and synthesis of new prostaglandin Dâ¿¿ receptor antagonists.Bioorg Med Chem2011
21982795Discovery of new orally active prostaglandin D2 receptor antagonists.Bioorg Med Chem2011
19109128Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production. J. Exp. Med. 1989. 170: 1415-1420.J Immunol2009
16522463Identification of basophils by a mAb directed against pro-major basic protein 1.J Allergy Clin Immunol2006
17023654Molecular loops in the galactic center: evidence for magnetic flotation.Science2006
15388164Discovery of a new class of potent, selective, and orally active prostaglandin D2 receptor antagonists.Bioorg Med Chem2004
15277762Expression of a single-chain antibody against indole-3-acetic acid in Escherichia coli.Biosci Biotechnol Biochem2004
15341946Discovery of orally active prostaglandin D2 receptor antagonists.Bioorg Med Chem Lett2004
15358295Development of prostaglandin D2 receptor antagonist: discovery of highly potent antagonists.Bioorg Med Chem2004
11823532Biological activities of ecalectin: a novel eosinophil-activating factor.J Immunol2002
11886844Regulation of galectin-9 expression and release in Jurkat T cell line cells.Glycobiology2002
10702134Global Simulations of Differentially Rotating Magnetized Disks: Formation of Low-beta Filaments and Structured Coronae.Astrophys J2000
10722666Requirement of divalent galactoside-binding activity of ecalectin/galectin-9 for eosinophil chemoattraction.J Biol Chem2000
10713266Molecular cloning and characterization of a novel gene encoding limonoid UDP-glucosyltransferase in Citrus.FEBS Lett2000
9642261Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes.J Biol Chem1998
9414284Interleukin-4 promotes the development of tryptase and chymase double-positive human mast cells accompanied by cell maturation.Blood1998
9395536The tryptase, mouse mast cell protease 7, exhibits anticoagulant activity in vivo and in vitro due to its ability to degrade fibrinogen in the presence of the diverse array of protease inhibitors in plasma.J Biol Chem1997
8858180Mast cells that reside at different locations in the jejunum of mice infected with Trichinella spiralis exhibit sequential changes in their granule ultrastructure and chymase phenotype.J Cell Biol1996
8816382CD1c restricts responses of mycobacteria-specific T cells. Evidence for antigen presentation by a second member of the human CD1 family.J Immunol1996
7540656Differentiation in vitro of hybrid eosinophil/basophil granulocytes: autocrine function of an eosinophil developmental intermediate.J Exp Med1995
7594606IgE-dependent activation of cytokine-primed mouse cultured mast cells induces a delayed phase of prostaglandin D2 generation via prostaglandin endoperoxide synthase-2.J Immunol1995
7642636Packaging of proteases and proteoglycans in the granules of mast cells and other hematopoietic cells. A cluster of histidines on mouse mast cell protease 7 regulates its binding to heparin serglycin proteoglycans.J Biol Chem1995
7531701c-kit ligand mediates increased expression of cytosolic phospholipase A2, prostaglandin endoperoxide synthase-1, and hematopoietic prostaglandin D2 synthase and increased IgE-dependent prostaglandin D2 generation in immature mouse mast cells.J Biol Chem1995
8071353Prostaglandin endoperoxide synthase-1 and -2 couple to different transmembrane stimuli to generate prostaglandin D2 in mouse bone marrow-derived mast cells.J Biol Chem1994
7682557Three-dimensional models of four mouse mast cell chymases. Identification of proteoglycan binding regions and protease-specific antigenic epitopes.J Biol Chem1993
8385251Effects of OP-41483.alpha-CD, a stable prostacyclin analog, on cultured endothelial cell dysfunction caused by 15(S)-hydroperoxy-5,8,11,13-eicosatetraenoic acid (15-HPETE) in vitro.Life Sci1993
8366756Effect of OP-41483.alpha-CD, a prostacyclin analog, on a clamp-induced endothelial injury in rats.Life Sci1993
1335763Establishment of a human T-cell line constitutively producing several eosinophil chemotactic lymphokines and their functional heterogeneity on eosinophils.Lymphokine Cytokine Res1992
1395793Interleukin-5 levels of pleural fluid and serum samples in a patient with PIE syndrome.Chest1992
1804311Functional heterogeneity of human eosinophil chemotactic lymphokines.Lymphokine Cytokine Res1991
1825384Anti-thrombotic effect of ONO-8809, a novel TXA2/PG endoperoxide receptor antagonist.Adv Prostaglandin Thromboxane Leukot Res1991
1988543Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production.J Exp Med1991
2090920Elevated expression of proto-oncogenes during interleukin-5-induced growth and differentiation of murine B lineage cells.Microbiol Immunol1990
2677210Transforming growth factor beta induces IgA production and acts additively with interleukin 5 for IgA production.J Exp Med1989
15493259Interleukin-5 induces maturation but not class switching of surface IgA-positive B cells into IgA-secreting cells.Immunology1989
  • 1 - 40 of 40

Recommended Authors

Daegu Gyeongbuk Institute of Science and Technology (DGIST)
Career Start Year 2003
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 1998
Number of shared co-authors 5
West Virginia University School of Medicine
Career Start Year 1992
Number of shared co-authors 0
VA San Diego Healthcare System Mission Valley Clinic
Career Start Year 1991
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1990
Number of shared co-authors 0
The University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1990
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Center for Technology Transfer and Commercialization, Vanderbilt University
Career Start Year 1988
Number of shared co-authors 0
Cincinnati Children's Hospital Medical Center
Career Start Year 1987
Number of shared co-authors 6
RIKEN Center for Integrative Medical Sciences
Career Start Year 1986
Number of shared co-authors 0
University of Washington
Career Start Year 1986
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1984
Number of shared co-authors 0
The University of Tokyo.
Career Start Year 1984
Number of shared co-authors 0
Frederick National Laboratory for Cancer Research
Career Start Year 1984
Number of shared co-authors 0
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 1
University of California Los Angeles
Career Start Year 1982
Number of shared co-authors 0
Yale University School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Niigata University of Health and Welfare
Career Start Year 1981
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute at Frederick
Career Start Year 1981
Number of shared co-authors 0
St. Anna Children's Hospital, Medical University of Vienna
Career Start Year 1980
Number of shared co-authors 0
Center for Computational and Integrative Biology, Massachusetts General Hospital
Career Start Year 1980
Number of shared co-authors 1
School of Medicine. University of Connecticut
Career Start Year 1977
Number of shared co-authors 0
National Cancer Institute
Career Start Year 1976
Number of shared co-authors 0
BioKien LLC
Career Start Year 1976
Number of shared co-authors 0
Center for Future Medical Research, Tokyo Medical University
Career Start Year 1975
Number of shared co-authors 0
Inflammatory Bowel and Immunobiology Research Institute, Cedars-Sinai Medical Center
Career Start Year 1975
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1970
Number of shared co-authors 0
RIKEN Center for Integrative Medical Sciences (IMS)
Career Start Year 1966
Number of shared co-authors 0

Collaborators

School of Biomedical Sciences and Pharmacy, University of Newcastle
Co-authored papers 5
Brigham & Women's Hospital
Co-authored papers 5
University of California San Francisco
Co-authored papers 3
Harvard Medical School
Co-authored papers 3
Brigham and Women's Hospital, Harvard Medical School
Co-authored papers 2
Harvard Medical School
Co-authored papers 2
Harvard University
Co-authored papers 2
Co-authored papers 1
College of Life Science and Engineering, Foshan University
Co-authored papers 1
Health Sciences University of Hokkaido
Co-authored papers 1
Johns Hopkins University School of Medicine
Co-authored papers 1
Brigham and Women's Hospital and Harvard Medical School
Co-authored papers 1